⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 1, 2002Retina

Preclinical and Phase 1a Clinical Evaluation of an Anti-Vegf Pegylated Aptamer (Eye001) for the Treatment of Exudative Age-Related Macular Degeneration

View Full Paper

Ask AI

Bookmark

Share

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 2002 study studied this question.

synapsesocial.com/papers/6a9d33cdc53a4841f767ebd5 https://doi.org/10.1097/00006982-200204000-00002

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Argon Laser Photocoagulation for Neovascular Maculopathy1991 · 414 citations
2Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin1999 · 2,198 citations
3Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid1983 · 3,988 citations
4Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen1989 · 5,034 citations